University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World Health Organization.

Immvention Therapeutix is partnering with Novo Nordisk to develop oral treatments for sickle cell disease (SCD) and other ...

Researchers propose a novel system that uses standing surface acoustic waves to separate circulating tumor cells from red blood cells with unprecedented precision and efficiency. The platform ...

Piper Sandler made a slight adjustment to the price target of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), bringing it down to $533 from the previous target of $535, while maintaining an ...

Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...

DARPA wants to know if modifying red blood cells can help warfighters "operate more effectively in dangerous or extreme ...

On Tuesday, RBC Capital Markets adjusted its price target for Sherwin-Williams (NYSE:SHW) stock, listed on the New York Stock Exchange under the ticker NYSE:SHW, reducing it to $438 from the previous ...

On Tuesday, RBC Capital Markets adjusted its price target for Sherwin-Williams (NYSE:SHW) stock, listed on the New York Stock Exchange under the ticker NYSE:SHW, reducing it to $438 from the ...

RBC Capital lowered the firm’s price target on Suncor (SU) to C$65 from C$66 and keeps an Outperform rating on the shares. The firm’s assumed multiples reflect the company’s integration and ...

KeyCorp raised shares of RBC Bearings from a “sector weight” rating to an “overweight” rating and set a $375.00 target price for the company in a report on Friday, November 22nd.